Clinical Social Workers in North Branford, CT Accepting Medicare
5 Clinical Social Workers found. Showing 1 - 5
 Mr. Joseph Vita, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 North St, North Branford, CT 06471 Phone: 203-488-8094 |
 Donielle Didiano, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 201 Branford Rd, North Branford, CT 06471 Phone: 203-376-3431 |
Shawna Holzer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 243 Twin Lakes Rd, North Branford, CT 06471 Phone: 646-596-3526 |
Ms. Melinda L Lazarus, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 53 Cedar Lake Rd, North Branford, CT 06471 Phone: 203-651-9203 |
Maria Cacace-mele, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1599 Foxon Rd, North Branford, CT 06471 Phone: 203-315-6014 |
News Archive
New York Times highlights shortfalls in transplant patient immunosuppressive drug coverage
Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit.
HHS launches website to provide consumers with public, private health coverage options
The U.S. Department of Health and Human Services today unveiled an innovative new on-line tool that will help consumers take control of their health care by connecting them to new information and resources that will help them access quality, affordable health care coverage. Called for by the Affordable Care Act, HealthCare.gov is the first website to provide consumers with both public and private health coverage options tailored specifically for their needs in a single, easy-to-use tool.
UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015
UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.
FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
› Verified 2 days ago
Pharmacists
Clinical Social Workers
Dentists
Counselors
Occupational Therapists
Psychologists